Hepatoma Research Gets Included in Emerging Sources Citation Index (ESCI)
We are delighted to announce that Hepatoma Research has been selected for inclusion in the Web of Science™ on June 21, 2023. Articles published after 2021, starting from volume 7, will be included in Emerging Sources Citation Index (ESCI). This achievement represents a major milestone for the journal and highlights its growing impact on the global scientific community.
ESCI, a comprehensive citation index launched by Clarivate Analytics, is an essential resource for researchers seeking high-quality, emerging research literature. Its rigorous evaluation process ensures that only journals with exceptional scientific rigor and impactful contributions are included. The inclusion of Hepatoma Research in the ESCI database is a testament to the journal's rigorous peer-review process and its commitment to publishing cutting-edge research in the field.
With its newfound recognition in the ESCI database, Hepatoma Research is poised to attract a broader readership and increase its citation impact, allowing researchers and clinicians worldwide to access the latest advancements in hepatoma research and further stimulating scientific progress in liver cancer research.
The Editorial Office thanks all Editorial Board members, authors, reviewers, and readers who have contributed to the journal's success. We remain committed to upholding the highest standards of scientific integrity and facilitating collaboration among experts, ultimately striving to improve patient outcomes and advance the fight against hepatocellular carcinoma.
About Hepatoma Research:
Hepatoma Research is an international peer-reviewed, gold open access, online academic journal founded by OAE Publishing Inc. (www.oaepublish.com) in April 2015. The journal aims to provide the best academic exchange platform in the field of liver cancer, including its occurrence, development, diagnosis, and treatment. The coverage also extends to other basic and clinical studies related to surgery, internal medicine, cell biology, pathology, pathophysiology, immunology, genetics, pharmacology, etc. The journal was accepted for Scopus in August 2021.
Journal website: https://oaepublish.com/hr
Online submission: https://oaemesas.com/login?JournalId=hr
ESCI, a comprehensive citation index launched by Clarivate Analytics, is an essential resource for researchers seeking high-quality, emerging research literature. Its rigorous evaluation process ensures that only journals with exceptional scientific rigor and impactful contributions are included. The inclusion of Hepatoma Research in the ESCI database is a testament to the journal's rigorous peer-review process and its commitment to publishing cutting-edge research in the field.
With its newfound recognition in the ESCI database, Hepatoma Research is poised to attract a broader readership and increase its citation impact, allowing researchers and clinicians worldwide to access the latest advancements in hepatoma research and further stimulating scientific progress in liver cancer research.
The Editorial Office thanks all Editorial Board members, authors, reviewers, and readers who have contributed to the journal's success. We remain committed to upholding the highest standards of scientific integrity and facilitating collaboration among experts, ultimately striving to improve patient outcomes and advance the fight against hepatocellular carcinoma.
About Hepatoma Research:
Hepatoma Research is an international peer-reviewed, gold open access, online academic journal founded by OAE Publishing Inc. (www.oaepublish.com) in April 2015. The journal aims to provide the best academic exchange platform in the field of liver cancer, including its occurrence, development, diagnosis, and treatment. The coverage also extends to other basic and clinical studies related to surgery, internal medicine, cell biology, pathology, pathophysiology, immunology, genetics, pharmacology, etc. The journal was accepted for Scopus in August 2021.
Journal website: https://oaepublish.com/hr
Online submission: https://oaemesas.com/login?JournalId=hr
